Diary

  • Thu
    09
    Dec
    2021

    10am - 12.30pmOnline, live event


    Description:
    Over the course the morning, Elaine guides you through the scientific concepts that underpin many of the most used targeted cancer treatments for solid tumours.

    Elaine begins by describing what we can and can't target, and the mechanisms of action of monoclonal antibodies and small molecules that block kinases. She then looks at the many treatments that block growth factor controlled signalling pathways. Finally, she turns her attention to other targets and to various biomarker tests to select the right approach for each patient.

    This morning is the first part of a virtual study day. On Friday 10 December it is followed by “Molecular Mechanisms of Immunotherapies for Solid Tumours”.

    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
    Cost:
    £50
    To book, contact: conferenceteam@rmh.nhs.uk or book online
    View the programme

  • Fri
    10
    Dec
    2021

    10am - 12.30pmOnline, live event


    Description:

    The focus of this morning is on cancer’s relationship with the immune system, and how this knowledge is being used to improve the outlook of people with various solid tumours. Elaine focuses much of her attention on the checkpoint inhibitor group of immunotherapies and highlights some of the lessons learned through the hundreds of clinical trials with checkpoint inhibitors that have taken place over the past decade.

    In the latter part of the morning Elaine looks at other technologies, such as CAR T cell therapy, vaccine-based treatments and oncolytic viruses.

    This morning is the second part of a virtual study day and follows on from “Molecular Mechanisms of Targeted Therapies for Solid Tumours” on Thursday 09 December.

    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
    Cost:
    £50
    To book, contact: conferenceteam@rmh.nhs.uk or book online
    View the programme

  • Thu
    03
    Feb
    2022
    Fri
    04
    Feb
    2022

    10am - 12.30pmOnline, live event


    Format:
    This is a live, virtual event. Each morning’s content is split over three pre-recorded videos of 30-40 minutes each. Elaine will be online throughout both mornings to interact with learners and answer questions in the live Q&A sessions that follow each video. The presentations will be available online for 30 days after the live event.


    Description:

    The aim of this course, spread over two mornings, is to provide learners with a good, general understanding of the biology, genetics and behaviours of many haematological cancers. Elaine also provides an up-to-date overview of modern systemic treatment approaches given to people with various haematological cancers. This includes CAR T cell therapy and other targeted approaches that have come through clinical trials in recent years.

    Elaine's goal is to explain the science that underpins each treatment. She also hopes to provide learners with a broad understanding of why treatments work well for some patients but not for others.

    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
    Cost:
    £50 per morning
    To book, contact: conferenceteam@rmh.nhs.uk

    View the programme for morning 1

    View the programme for morning 2